Liver Protection of a Low-Polarity Fraction from Ficus pandurata Hance, Prepared by Supercritical CO 2 Fluid Extraction, on CCl 4 -Induced Acute Liver Injury in Mice via Inhibiting Apoptosis and Ferroptosis Mediated by Strengthened Antioxidation.
Weibo DaiXiaoyan PangWeiwen PengXinyi ZhanChang ChenWenchang ZhaoCongyan ZengQuanxi MeiQilei ChenWeihong KuangZhanping GouXianjing HuPublished in: Molecules (Basel, Switzerland) (2023)
Ficus pandurata Hance (FPH) is a Chinese herbal medicine widely used for health care. This study was designed to investigate the alleviation efficacy of the low-polarity ingredients of FPH (FPHLP), prepared by supercritical CO 2 fluid extraction technology, against CCl 4 -induced acute liver injury (ALI) in mice and uncover its underlying mechanism. The results showed that FPHLP had a good antioxidative effect determined by the DPPH free radical scavenging activity test and T-AOC assay. The in vivo study showed that FPHLP dose-dependently protected against liver damage via detection of ALT, AST, and LDH levels and changes in liver histopathology. The antioxidative stress properties of FPHLP suppressed ALI by increasing levels of GSH, Nrf2, HO-1, and Trx-1 and reducing levels of ROS and MDA and the expression of Keap1. FPHLP significantly reduced the level of Fe 2+ and expression of TfR1, xCT/SLC7A11, and Bcl2, while increasing the expression of GPX4, FTH1, cleaved PARP, Bax, and cleaved caspase 3. The results demonstrated that FPHLP protected mouse liver from injury induced by CCl 4 via suppression of apoptosis and ferroptosis. This study suggests that FPHLP can be used for liver damage protection in humans, which strongly supports its traditional use as a herbal medicine.
Keyphrases
- liver injury
- drug induced
- cell death
- oxidative stress
- healthcare
- poor prognosis
- cell cycle arrest
- dna damage
- adipose tissue
- endoplasmic reticulum stress
- liver fibrosis
- cell proliferation
- skeletal muscle
- metabolic syndrome
- binding protein
- high throughput
- small molecule
- stress induced
- insulin resistance
- dna repair
- health insurance